Skip to main content
logo
Double Medical Technology Inc. (SHE:002901)
China flag China · Delayed Price · Currency is CNY
40.86
+0.30 (0.74%)
Sep 30, 2026, 3:04 PM CST

Double Medical Technology Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Market Capitalization
16,52319,26112,57916,80514,06220,310
Market Cap Growth
-23.95%53.12%-25.15%19.50%-30.76%-31.23%
Enterprise Value
15,13618,30911,78315,84712,89119,519
Last Close Price
40.8646.7530.0439.1732.8448.14

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
PE Ratio
23.6232.1235.25285.02151.9330.17
Forward PE
24.4732.8433.0738.0215.4260.69
PS Ratio
6.057.415.8910.969.8110.18
PB Ratio
4.595.233.955.324.537.85
P/TBV Ratio
4.965.684.365.895.058.85
P/FCF Ratio
23.6127.6073.20--46.36
P/OCF Ratio
19.5723.1728.44227.43109.4830.17

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
EV/Sales Ratio
5.547.045.5210.348.999.79
EV/EBITDA Ratio
18.9926.2926.32130.66110.0724.96
EV/EBIT Ratio
22.9232.0635.44813.83417.1827.21
EV/FCF Ratio
21.6226.2468.57--44.55

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Debt / Equity Ratio
0.120.090.120.190.020.01
Debt / EBITDA Ratio
0.530.450.844.570.550.03
Debt / FCF Ratio
0.600.452.24--0.05
Net Debt / Equity Ratio
-0.41-0.39-0.27-0.34-0.41-0.46
Net Debt / EBITDA Ratio
-1.86-2.06-1.93-8.75-10.95-1.53
Net Debt / FCF Ratio
-2.09-2.05-5.024.588.19-2.74
Asset Turnover
0.570.560.470.360.390.66
Inventory Turnover
0.640.660.580.500.420.53
Quick Ratio
1.882.351.591.662.352.34
Current Ratio
3.023.802.992.743.803.32
Return on Equity (ROE)
22.09%18.55%12.15%2.76%3.85%29.29%
Return on Assets (ROA)
8.70%7.64%4.59%0.28%0.53%14.90%
Return on Invested Capital (ROIC)
25.51%21.80%13.54%0.86%1.43%50.99%
Return on Capital Employed (ROCE)
16.70%14.10%9.60%0.60%1.00%27.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Earnings Yield
4.29%3.11%2.84%0.35%0.66%3.31%
FCF Yield
4.24%3.62%1.37%-1.38%-1.11%2.16%
Dividend Yield
1.47%1.28%1.66%0.64%-1.04%
Payout Ratio
1.42%35.75%33.09%16.00%226.22%48.14%
Buyback Yield / Dilution
0.35%1.68%1.49%-0.10%-4.35%-0.52%
Total Shareholder Return
1.82%2.96%3.15%0.53%-4.35%0.52%